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Materials and Methods
The experiments were performed on female mongrel dogs, weighing between 18 and 22 kg, fed a standard diet. The protocol and the size of the experimental sample were approved by the Institutional Animal Care and Use Committee. In 12 dogs the experiments were performed during anesthesia induced with sodium pentobarbital (30 mg/kg i.v.) and maintained relatively constant by periodic administration of 5 mg/kg/hr. This anesthesia proto-col does not alter hemodynamics over 8 hours of observation. The temperatures of the room and the animals were kept constant at 220 C and 370 C, respectively.
After placement of an endotracheal tube, a catheter was positioned into the abdominal aorta for continuous monitoring of pulsatile and mean arterial pressure, and a Swan-Ganz thermodilution catheter was placed in the pulmonary artery for continuous measurement of right atrial and pulmonary capillary wedge pressures. Cardiac output and the derived parameters were obtained from the average of three to five thermodilution curves. Heart rate was continuously recorded.
Blood samples for measurement of plasma levels of ANF, renin activity (PRA), aldosterone, and hematocrit were obtained from the arterial line, while blood for venous plasma ANF and cyclic GMP (cGMP) was obtained from a catheter positioned in the inferior vena cava. A Foley catheter was inserted into the bladder for urine collection.
To evaluate the possible influence of anesthesia, studies were also performed in a separate group of awake dogs (n=5) previously instrumented with vascular catheters routed subcutaneously to the dorsal neck area and exteriorized under aseptic conditions. These animals were studied by the same protocol while resting quietly in loose canvas sling supports.
During placement of catheters and throughout the study, the animals received an infusion of saline (0.3 ml/min) containing 50 ,Ci/l [14C]inulin and 200 ,uCi/l p-amino[3H]hippuric acid for determination of the clearance of inulin and of PAH, respectively.
After three 15-minute baseline clearance periods, the animals received a rapid saline load (2.5% of body weight of 0.9% NaCl over 45 minutes); subsequently, three additional 15-minute clearances were performed. At the end of each period and throughout the experiment, urinary and blood losses were replaced with saline. After urine output appeared to be constant, endogenous formation of Ang II was inhibited by an intravenous dose of enalaprilat (0.15 mg/kg body wt) reported to produce immediate and sustained inhibition of angiotensin-converting enzyme (CEI) Figure 1 shows the behavior of plasma ANF and hemodynamic parameters in anesthetized dogs. Volume expansion increased right atrial and pulmonary wedge pressures and both arterial and venous plasma ANFs, as well as the arteriovenous difference across the heart (from 4.1±1 to 6.3±2 fmol/ml). These changes were associated with the expected hemodilution. CEI did not significantly modify atrial pressures and plasma ANF levels. Detailed analysis showed that CEI indeed reduced arterial ANF levels in four dogs, while it did not change or increase ANF in the remaining four animals.
Graded infusion of Ang II caused progressive increases in blood pressure and systemic vascular resistance, which became significant at 2.5 ng/kg/min. Opposite changes in stroke volume occurred ( Figure   1 ). Right and left atrial pressures and hematocrit were unchanged during Ang II infusion ( Figure 1 Figure 4 . The animals were divided into two groups of four dogs each according to the response of plasma ANF levels to CEI. The first group included the dogs showing a decrease in arterial ANF levels in response to CEI, which also showed the greatest ANF increase for each dose of Ang II ("ANF responders"). The second group included the dogs in which CEI did not cause a reduction in plasma ANF levels and in which Ang II caused smaller ANF increases. Baseline values of ANF and of other parameters were not different in the two subgroups (see legend to Figure 4) . Figure 4 shows that in the ANF responders, plasma aldosterone failed to increase in response to any dose of Ang II administered. This is in contrast to the marked plasma aldosterone response (to 300% and 500% of control) at the two highest rates of Ang II infusion in the dogs having smaller ANF responses. PRA fell significantly in both subgroups, but a much greater fall was associated with the largest ANF responses, since at 2.5 and 5 ng/kg/min, PRA fell to 35% and 20% of control (versus 80% and 55% of control in the less responsive dogs).
The sodium-retaining effects of Ang II also varied, although net sodium retention occurred in all animals. A dose-dependent fall in the sodium excretion rate with increasing doses of Ang II was observed only in the dogs having lesser ANF response, while in the ANF responders there was no further sodium retention beyond the first dose of ANF. At 5 and 10 ng/kg/min, the sodium excretion rate had fallen to only 75% of control in the ANF responders, while it was as low as 30% of control in the low ANF responders. This different pattern was observed despite a comparable rise in systemic blood and atrial pressures in the two subgroups (Figure 4) . Discussion We examined the effect of low doses of Ang II on plasma ANF levels in volume-replete anesthetized or conscious dogs and demonstrated stimulation of ANF secretion, which could not be accounted for by hemodynamic responses to Ang II. The doses of Ang II used in our study, which should result in circulating levels within the physiological range,17 were able to increase plasma ANF without changing atrial pressures, heart rate, or hematocrit. While blood pressure did increase, the rise in ANF was not correlated with the associated changes in systemic blood pressure. Our study suggests that the rise in plasma immunoreactive ANF induced by Ang II is due to an increase in its secretion rather than a decrease in its metabolic clearance rate, since the arteriovenous differences of ANF across the heart also increased during Ang II. Therefore, Ang II increases secretion of ANF by mechanisms other than its systemic hemodynamic actions, although it cannot be completely ruled out that the increase in systemic blood pressure may represent a contributory factor, especially at high doses of Ang II. suggesting that blood pressure differences did not account for different natriuretic or ANF responses in the two groups. Together with the parallel rise in plasma cGMP during Ang II infusion, these observations suggest that increases in plasma ANF within the physiological range may have biological relevance with respect to volume regulation.
In conclusion, our study demonstrates that Ang lI-induced stimulation of ANF secretion occurs independently of the changes in atrial pressures and is not correlated with the increase in systemic arterial pressure. Our data also suggest that the Ang IIinduced rise in plasma ANF levels modulates three major actions of Ang II, appearing to counteract the sodium-retaining effect and the increase in aldosterone production by Ang II and to potentiate the suppression of renin release. This finding may have particular relevance to pathological states in which increased levels of Ang II and ANF coexist.
